AstraZeneca

RNS Announcement

RNS Number : 4287F

FTSE Russell

15 July 2021

AstraZeneca (UK): Acquisition of Alexion Pharmaceuticals (USA)
Changes in FTSE UK Index Series

15 July 2021

Subject to the completion of the cash and stock acquistion of Alexion Pharmaceuticals (USA, non-constituent) by AstraZeneca (UK, constituent), please see details of affected indexes and effective dates below:

Index	Effective From Start of Trading
FTSE 100 Index	21 July 2021
FTSE 350 Index	21 July 2021
FTSE All-Share Index	21 July 2021
FTSE 350 Higher Yield Index	21 July 2021
Techmark All Share Index	21 July 2021

For further information please contact FTSE Russell Client Services at [email protected] or call:

Australia	+1800 653 680
Hong Kong	+852 2164 3333
Japan	+81 3 4563 6346
London	+44 (0) 20 7866 1810
New York	+1866 551 0617

Alternatively please visit our website at www.ftserussell.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FTSSFFFMIEFSEFW

RNS metadata

Title: AstraZeneca
Time: 17:30:01
Date: 15 Jul 2021
Category: Miscellaneous
ID: 4287F